Outcome of MS relapses in the era of disease-modifying therapy

Outcome of MS relapses in the era of disease-modifying therapy

Abstract Background In multiple sclerosis (MS), neurological disability results from incomplete remission of relapses and from relapse-independent progression. Intravenous high dose methylprednisolone (IVMP) is the established standard treatment to accelerate clinical relapse remission, although som...

Full description

Bibliographic Details
Main Authors: Muriel Stoppe, Maria Busch, Luise Krizek, Florian Then Bergh
Format: Article
Language:English
Published: BMC 2017-08-01
Series:BMC Neurology
Subjects:
Multiple Sclerosis
Relapse
Relapse treatment
Relapse management
Relapse outcome
Methylprednisolone
Online Access:http://link.springer.com/article/10.1186/s12883-017-0927-x

Internet

http://link.springer.com/article/10.1186/s12883-017-0927-x

Similar Items